Description: The company aims to creat a simulation tool PathwayModeler capable to satisfy the need to simulate the dynamics of biological pathways. The users of this computer program are the research staff in the pharmaceutical companies and academic labs.
BSI PROTEOMICS
Verifying an innovative solution to solving membrane protein structures
Gaithersburg, MD
National Institute of Standards and Technology (NIST)
Description: BSI is a drug enabling technology company. The new science of structure based drug design deals with designing drugs that interact wth the erratic proteins that are in the disease pathway. The company's platform of technologies deals with determining the molecular structure of these target proteins and supporting the drug design process by determining how effectively the drug candidate interacts molecularly as a blocker or inhibitor. The company's technology is based on crystalizing the protein to be studied and then with powerful X-ray beams (at a synchrotron) collecting X-ray data which permits solving the moecular structure.
Promogen, Inc.
Production of Neuroblastoma Cancer-Specific Gene Promoter/Enhancer Cassettes
Gaithersburg
University of Maryland, Baltimore
Description: Promogen is involved in developing innovative gene expression technologies. Promogen plans to produce a line of synthetic promoters capable of targeting gene expression to specific cell types with unprecedented levels of precision. It will adapt the technology for the development of cancer gene therapy drugs targeting neuroblastoma and various other cancer types. Promogen is also developing enhanced constitutive promoters to be used in recombinant gene therapeutics production systems for a dramatic reduction in manufacturing costs. The company has obtained a patent on its platform technology and it expects to generate revenue via licensing to companies interested in this technology.
INTELLITECH MICROSYSTEMS, INC.
Development of UAVs in precision agriculture.
Bowie
Beltsville Agricultural Research Center (BARC)
Description: IntelliTech Microsystems, Inc. is one of Maryland's leading manufacturers of Robotic Systems including Unmanned Aerial Vehicles (UAVs). IntelliTech has defined a UAV solution for the emerging technology of Precision Agriculture (PA). Aerial photos of farmer's fields are used to detect crop water stress, nutrient deficiency, and insect and disease infestations. These data are used to determine the precise amount of water, fertilizer and insecticide to be applied to the field, minimizing waste and mitigating runoff damage to ecologically sensitive environments such as the Chesapeake Bay. Maryland farmers will benefit by millions of dollars in cost savings as well as vastly improving their yields.
Sensics, Inc.
SkyVizor provides a high resolution image across an ultra-wide field of view headset.
Baltimore, MD
Johns Hopkins University
Description: The Sensics SkyVizor provides a high resolution image across an ultra-wide field of view headset. The SkyVizor allows product designers to reduce their dependence on physical prototypes. The SkyVizor can also be used as a platform for a compact training simulator.
Sensics, Inc.
Head-mounted VR Display
Baltimore
Naval Air Warfare Center (NAVAIR)
Description: Develop software infrastructure to display dimensionally accurate, photo-realistic 3D models in the Sensics wide field of view head-mounted display.
TECHNOSYS, INC.
Fiber Optics Comm Systems
Ellicott City
Naval Air Warfare Center (NAVAIR)
Description: TechnoSys is developing a fiber optic-based intercommunication system for multi-place military and civilian aircraft. The fiber optic system is less susceptible than wire systems to electromagnetic interference and noise.
20/20 GENESYSTEMS, INC.
Protein function identification layered membranes platform technology (P-FILM).
Rockville, MD
National Institutes of Health (NIH)
Description: 20/20 Gene Systems, Inc. (“20/20”) is a biotechnology company that develops and commercializes innovative identification and detection products for proteins, the building blocks of life. The company’s proprietary technology addresses three large and growing markets: life science research, homeland security and diagnostic pathology.
20/20 GENESYSTEMS, INC.
Development of an Assay for Biomarkers for Chemical Exposure in Hair Follicles
Rockville
Aberdeen Proving Ground (APG)
Description: Working under a Cooperative Research and Development Agreement (CRADA) in collaboration with the Edgewood Chemical Biological Center at Aberdeen Proving Ground, 20/20 GeneSystems will create non-invasive test kits for exposure to chemical weapons agents by measuring the levels of key proteins in hair follicles
4Cyte
Novel glycosidase inhibitors as anti-diabetic therapeutics.
Clarksville, MD
University of Maryland, Baltimore County
Description: 4Cyte Therapeutics Inc. is a start-up stage biotech company devoted to the discovery and development of novel drugs to treat people with metabolic disorders such as diabetes, obesity and Metabolic Syndrome. The Company's business strategy is to in-license proprietary compounds and targets and use high throughput technology to idenitfy, prioritize and develop lead compounds through early-phase clinical testing. Currently, 4Cyte is working on several alpha-glycosidase inhibitor licensed from the University of Maryland Baltimore County on an exclusive basis.
Maryland Technology Development Corporation (TEDCO)
5565 Sterrett Place Suite 214, Columbia, Maryland 21044
(410) 740-9442, fax (410) 740-9422 1-800-305-5556 info@marylandtedco.org
